25 March 2021 - final results
The specialist designer and manufacturer of specialist instruments for minimally invasive surgery has announced results for 2020 which have come in much as expected. Revenues for the year fell sharply to £6.3m (2019: £10.7m) as elective surgical procedures were postponed or cancelled in all major markets, and this resulted in an adjusted loss before tax of £1.75m (2019: adjusted pre-tax profit of £0.22m). However, although these are clearly not great figures the results offer encouragement for investors. After the low point in May 2020, revenues have begun to recover and . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
